gemcitabine has been researched along with Syndrome in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasanov, M; Hernandez, CMR; Konoplev, SN | 1 |
| Emerich, J; Gołka, KA; Kobierski, J; Milczek, T | 1 |
| Depisch, D; Haider, K; Kornek, GV; Kwasny, W; Lang, F; Raderer, M; Scheithauer, W; Schmid, K; Schneeweiss, B; Schüll, B; Ulrich-Pur, H | 1 |
| Newlands, ES; Partridge, WJ; Rangi, PS; Waldman, AD | 1 |
| Billemont, B; Bourry, E; Brocheriou, I; Casimir, N; Deray, G; Isnard-Bagnis, C; Izzedine, H; Karie, S; Launay-Vacher, V; Mercadal, L; Rixe, O; Saeb, S; Tostivint, I | 1 |
| Awwad, E; Cacayorin, ED; Dunphy, F; Nassif, AS; Perman, W; Russell, MT | 1 |
1 review(s) available for gemcitabine and Syndrome
| Article | Year |
|---|---|
Gemcitabine-induced thrombotic microangiopathy: a systematic review.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Incidence; Kidney; Microcirculation; Retrospective Studies; Syndrome; Thrombosis | 2006 |
1 trial(s) available for gemcitabine and Syndrome
| Article | Year |
|---|---|
Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gemcitabine; Hand, Foot and Mouth Disease; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Survival Rate; Syndrome; Treatment Outcome | 2003 |
4 other study(ies) available for gemcitabine and Syndrome
| Article | Year |
|---|---|
Nivolumab-induced cold agglutinin syndrome successfully treated with rituximab.
Topics: Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Breast Neoplasms; Carboplatin; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, B-Cell, Marginal Zone; Neoplasms, Second Primary; Nivolumab; Rituximab; Syndrome | 2018 |
[Phalanges necrosis--a rare manifestation of "hand-foot" syndrome induced by gemcitabine used in the second--line therapy for progressive ovarian cancer. A case report].
Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Finger Phalanges; Foot Dermatoses; Gemcitabine; Hand Dermatoses; Humans; Necrosis; Ovarian Neoplasms; Syndrome | 2009 |
Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia.
Topics: Anesthesia, General; Antimetabolites, Antineoplastic; Blood Pressure; Brain; Brain Diseases; Deoxycytidine; Diffusion Magnetic Resonance Imaging; Female; Gemcitabine; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy; Syndrome; Water-Electrolyte Balance | 2005 |
Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings.
Topics: Antimetabolites, Antineoplastic; Brain; Brain Injuries; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Female; Gemcitabine; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Middle Aged; Syndrome | 2001 |